An antibody, conjugated to Cy5 fluorophores, raised against EpCAM that is expressed on the cell membranes of most carcinomas, and an antibody conjugated to FITC fluorophores prepared against CD44, another cell membrane protein expressed on tumors of epithelial origin, were used. The gene discussed is EPCAM; the disease is carcinoma.